Vincerx Pharma Inc (VINC)
0.8771
-0.05
(-5.69%)
USD |
NASDAQ |
May 03, 16:00
0.877
0.00 (0.00%)
After-Hours: 20:00
Vincerx Pharma 1 Year Total Returns (Daily): -44.49% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -44.49% |
May 02, 2024 | -40.00% |
May 01, 2024 | -39.51% |
April 30, 2024 | -36.87% |
April 29, 2024 | -35.87% |
April 26, 2024 | -42.97% |
April 25, 2024 | -27.10% |
April 24, 2024 | -15.45% |
April 23, 2024 | -0.02% |
April 22, 2024 | -8.55% |
April 19, 2024 | -14.14% |
April 18, 2024 | -11.76% |
April 17, 2024 | -5.92% |
April 16, 2024 | -4.39% |
April 15, 2024 | -11.48% |
April 12, 2024 | 2.08% |
April 11, 2024 | 6.72% |
April 10, 2024 | 13.64% |
April 09, 2024 | 9.79% |
April 08, 2024 | 395.1% |
April 05, 2024 | 465.2% |
April 04, 2024 | 480.4% |
April 03, 2024 | 580.4% |
April 02, 2024 | 512.5% |
April 01, 2024 | 462.5% |
Date | Value |
---|---|
March 28, 2024 | 432.6% |
March 27, 2024 | 544.7% |
March 26, 2024 | 438.9% |
March 25, 2024 | 422.1% |
March 22, 2024 | 439.8% |
March 21, 2024 | 467.7% |
March 20, 2024 | 590.8% |
March 19, 2024 | 536.4% |
March 18, 2024 | 396.0% |
March 15, 2024 | 486.8% |
March 14, 2024 | 530.5% |
March 13, 2024 | 594.8% |
March 12, 2024 | 535.5% |
March 11, 2024 | 694.1% |
March 08, 2024 | 594.7% |
March 07, 2024 | 536.2% |
March 06, 2024 | 506.0% |
March 05, 2024 | 357.0% |
March 04, 2024 | 328.1% |
March 01, 2024 | 297.2% |
February 29, 2024 | 223.3% |
February 28, 2024 | 227.6% |
February 27, 2024 | 268.2% |
February 26, 2024 | 236.8% |
February 23, 2024 | 206.0% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-94.33%
Minimum
Nov 21 2022
694.1%
Maximum
Mar 11 2024
-18.32%
Average
-40.26%
Median
Dec 20 2021
1 Year Total Returns (Daily) Benchmarks
Trxade Health Inc | 114.5% |
MyMD Pharmaceuticals Inc | -93.93% |
Acrivon Therapeutics Inc | -23.89% |
Ligand Pharmaceuticals Inc | -2.03% |
Regulus Therapeutics Inc | 103.8% |